首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison of 18F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix
Authors:Theresia?Sarabhai  author-information"  >  author-information__contact u-icon-before"  >  mailto:Theresia-catharina.sarabhai@uk-essen.de"   title="  Theresia-catharina.sarabhai@uk-essen.de"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Benedikt?M.?Schaarschmidt,Axel?Wetter,Julian?Kirchner,Bahriye?Aktas,Michael?Forsting,Verena?Ruhlmann,Ken?Herrmann,Lale?Umutlu,Johannes?Grueneisen
Affiliation:1.Department of Diagnostic and Interventional Radiology and Neuroradiology,University Hospital Essen, University of Duisburg-Essen,Essen,Germany;2.Department of Diagnostic and Interventional Radiology, Medical Faculty,University Dusseldorf,Dusseldorf,Germany;3.Department of Obstetrics and Gynecology,University Hospital Essen, University of Duisburg-Essen,Essen,Germany;4.Department of Nuclear Medicine,University Hospital Essen, University of Duisburg-Essen,Essen,Germany
Abstract:

Purpose

The aim of the present study was to assess and compare the diagnostic performance of integrated PET/MRI and MRI alone for local tumor evaluation and whole-body tumor staging of primary cervical cancers. In addition, the corresponding impact on further patient management of the two imaging modalities was assessed.

Methods

A total of 53 consecutive patients with histopathological verification of a primary cervical cancer were prospectively enrolled for a whole-body 18F-FDG PET/MRI examination. Two experienced physicians analyzed the MRI data, in consensus, followed by a second reading session of the PET/MRI datasets. The readers were asked to perform a dedicated TNM staging in accordance with the 7th edition of the AJCC staging manual. Subsequently, the results of MRI and PET/MRI were discussed in a simulated interdisciplinary tumor board and therapeutic decisions based on both imaging modalities were recorded. Results from histopathology and cross-sectional imaging follow-up served as the reference standard.

Results

PET/MRI allowed for a correct determination of the T stage in 45/53 (85%) cases, while MRI alone enabled a correct identification of the tumor stage in 46/53 (87%) cases. In 24 of the 53 patients, lymph node metastases were present. For the detection of nodal-positive patients, sensitivity, specificity and accuracy of PET/MRI were 83%, 90% and 87%, respectively. The respective values for MRI alone were 71%, 83% and 77%. In addition, PET/MRI showed higher values for the detection of distant metastases than MRI alone (sensitivity: 87% vs. 67%, specificity: 92% vs. 90%, diagnostic accuracy: 91% vs. 83%). Among the patients with discrepant staging results in the two imaging modalities, PET/MRI enabled correct treatment recommendations for a higher number (n = 9) of patients than MRI alone (n = 3).

Conclusion

The present results demonstrate the successful application of integrated PET/MRI imaging for whole-body tumor staging of cervical cancer patients, enabling improved treatment planning when compared to MRI alone.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号